Literature DB >> 2828674

Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.

R Ray1, B J Glaze, R W Compans.   

Abstract

Affinity-purified hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of human parainfluenza virus type 3 (P13 virus) were used to investigate their role in the induction of a protective immune response following immunization of hamsters. The efficacy of immunization with the glycoprotein antigens was tested by challenge infection. Results of virus recovery from lungs and trachea demonstrated that although immunization with HN or F alone induced an antibody response to the respective glycoproteins, it did not provide a significant level of protection. However, immunization with a mixture of both purified glycoproteins induced higher virus-neutralizing activity in bronchial lavages and afforded complete protection from challenge infection. Similarly, incomplete protection was observed after passive transfer of monospecific rabbit antibody to the purified HN or F in baby hamsters. On the other hand, passive transfer of a mixture of antibodies to HN and F conferred a higher level of protection. Thus, the presence of antibody to both glycoproteins of P13 virus may be essential for protective immunity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828674      PMCID: PMC253632          DOI: 10.1128/JVI.62.3.783-787.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION.

Authors:  R M CHANOCK; R H PARROTT
Journal:  Pediatrics       Date:  1965-07       Impact factor: 7.124

2.  Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine.

Authors:  R Ray; V E Brown; R W Compans
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

3.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells.

Authors:  M Homma; M Ouchi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Viruses, Mycoplasma pneumoniae and bacteria associated with lower respiratory tract disease among infants.

Authors:  M A Mufson; H E Krause; H E Mocega; F W Dawson
Journal:  Am J Epidemiol       Date:  1970-02       Impact factor: 4.897

6.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

Review 7.  The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.

Authors:  P W Choppin; A Scheid
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

8.  Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children.

Authors:  W P Glezen; A L Frank; L H Taber; J A Kasel
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

9.  Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.

Authors:  J A Kasel; A L Frank; W A Keitel; L H Taber; W P Glezen
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

Review 10.  Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.

Authors:  D C Merz; A Scheid; P W Choppin
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  6 in total

1.  Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

Authors:  R Ray; K Meyer; F K Newman; R B Belshe
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

2.  Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.

Authors:  K L van Wyke Coelingh; C C Winter; E L Tierney; S L Hall; W T London; H W Kim; R M Chanock; B R Murphy
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia.

Authors:  D D Porter; G A Prince; V G Hemming; H G Porter
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 5.  Respiratory viral infections in the elderly.

Authors:  J Treanor; A Falsey
Journal:  Antiviral Res       Date:  1999-12-15       Impact factor: 5.970

6.  Characterization of haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed by a recombinant baculovirus.

Authors:  M Niikura; Y Matsuura; M Hattori; M Onuma; T Mikami
Journal:  Virus Res       Date:  1991-06       Impact factor: 3.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.